Skip to main content
Equibles
SCYX logo

SCYX · Scynexis Inc · Metrics

Track SCYX — free

Use SCYX with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research SCYX.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$3.79 -0.02 (-0.39%) At close · Oct 21
Rebalance outlook locked
Market Cap
$37.81M
Shares
9.95M
Volume · Oct 21 69.92K Avg daily vol (3M) 280.04K

SCYX metrics

70 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$3.79
Market cap
$37.81M

Price action

20 metrics
Price change (1W)
-4.8%
Price change (30D)
-13.6%
Price change (3M)
-6.2%
Price change (6M)
—
Price change (YTD)
—
Price change (1Y)
—
Trailing year
Price change (5Y)
—
52-week high
—
52-week low
—
Change from 52-week high
—
Change from 52-week low
—
Annualized volatility
84.8%
Annualized volatility (3M)
89.5%
Beta
—
RSI (14D)
35.9
Price vs SMA 50
-20.2%
Price vs SMA 200
—
Avg volume (3M)
279,551
Relative volume
0.2
Average dollar volume
$1.32M

Company

3 metrics
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Shares outstanding
9.95M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
-0.9×
EV / EBITDA
—
EV / EBIT
—
P / sales
1.9×
reciprocal yield 52.8%
P / book
0.5
reciprocal yield 183.8%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-28.1%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
-0.9×
EV / revenue historical average (5Y)
2.0×
reciprocal yield 49.9%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2022-11-09

Profitability

9 metrics
Gross margin
—
Operating margin
-117.7%
Trailing 12 months
Net margin
-53.3%
Gross profit (TTM)
$2.90M
Operating profit (TTM)
−$22.62M
Net income (TTM)
−$10.23M
Trailing 12 months
Diluted EPS (TTM)
$-2.10
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
$3.02
Gross profit per diluted share (TTM)
$28.75
Operating profit per diluted share (TTM)
$-3.01
EBITDA per diluted share (TTM)
$-6.12
Net income per diluted share (TTM)
$-2.16
Operating cash flow per diluted share (TTM)
$-1.02
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
$3.86
Stock compensation per diluted share (TTM)
$0.33
Book value per share
$9.07

Growth

11 metrics
Revenue growth YoY
-82.8%
Year over year
Net income growth YoY
—
Revenue (TTM)
$19.21M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+90.1%
Year over year · more shares
Revenue CAGR (3Y)
+59.4%
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-15.3%
Return on assets
-13.7%
Debt / equity
0.0
Current ratio
9.7
EBITDA (TTM)
−$37.12M
Free cash flow (TTM)
—
Quick ratio
—
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$54.08M
Latest balance sheet
Cash & equivalents
$10.49M
Total assets
$74.97M
Total debt
$0

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$13.31M
Capital expenditures (TTM)
$0
R&D (TTM)
$26.24M
SG&A (TTM)
$15.59M
Stock compensation (TTM)
$2.36M
R&D / revenue
136.6%
Stock compensation / revenue
12.3%

Ownership (13F)

9 metrics
13F filers
40
13F filer change QoQ
-6
Institutional ownership
51.9%
Conviction holders (share of 13F filers)
0.0%
Crowding (high-turnover and private-fund holders)
45.1%
Private-fund adviser ownership
43.5%
Active holders' share change QoQ
+37.8%
Holder tenure
3.4
Price vs estimated holder cost
-42.1%

Ownership (registered funds)

1 metrics
Index-fund ownership
2.9%

Short interest

3 metrics
Short interest
6.0%
Latest settlement · 1.0 days to cover
Days to cover
1.0d
Short-squeeze score
60 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1178253 CUSIP 811292309 13F (30d) 2 filings 2 filers Visit website Investor relations